Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study
International Journal of Cancer · 2025
DOI: 10.1002/ijc.70045 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Koen de Nijs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, ZonMw.
Abstract (Originalsprache)
The Dutch–Belgian lung cancer (LC) screening trial (Nederlands–Leuvens Longkanker Screenings Onderzoek [NELSON]) demonstrated low‐dose computed tomography (CT) reduces LC mortality by 24% among men. The NELSON protocol differed from previous trials in the eligibility criteria, the use of volume‐based nodule management, and increasing screening intervals. The early‐stage sensitivity of the protocol is pivotal in determining the optimal screening strategy, such as the interval and age range. The MIcrosimulation SCreening ANalysis‐Lung natural history model was used to reproduce LC incidence and mortality by detection method (clinical or screen‐detected), sex, histology, and stage in the NELSON trial based on individual‐level data. We evaluated screening effectiveness by stage and histology, accounting for population characteristics, trial design, and LC epidemiology. We find stage IA non‐small cell LC (NSCLC) sensitivity of 24.6% (other NSCLC) to 41.0% (adenocarcinoma) at baseline screening. At repeat screening rounds, we find this increased to 70.9% for stage IA adenocarcinoma. For stage IB, the sensitivity by histology ranges from 26.4% to 77.1%; for stage II, 39.6%–81.9%. Upon detection, the probability of LC mortality prevention is estimated at 83% for stage IA. The sensitivity for detecting early‐stage LC is found to depend on the histology of cancer and is increased for adenocarcinoma at repeat screenings. Despite a low rate of referral to follow‐up screening in the NELSON trial, early‐stage CT sensitivity and the probability of mortality prevention were similar to previous estimates from the National Lung cancer Screening Trial. Previously demonstrated screening effectiveness may be maintained when implementing new programs, while reducing unnecessary follow‐up when considering NELSON evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands.
- Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Epidemiology, Rijksuniversiteit Groningen, Groningen, The Netherlands.
- UMC Groningen-University Medical Center Groningen, Institute for Diagnostic Accuracy, Groningen, The Netherlands.
- Department of Pulmonary Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Koen de Nijs, Kevin Ten Haaf, Harry J de Koning
Förderung
- European Commission
- ZonMw
Zitieren
APA
de Nijs, K., Ten Haaf, K., Hubert, J., Moldovanu, D., van der Aalst, C. M., Groen, H. J. M., de Jong, P. A., Heuvelmans, M. A., Oudkerk, M., & de Koning, H. J. (2025). Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study. International Journal of Cancer. https://doi.org/10.1002/ijc.70045
Vancouver
de Nijs K, Ten Haaf K, Hubert J, Moldovanu D, van der Aalst CM, Groen HJM, et al. Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study. International Journal of Cancer. 2025. doi:10.1002/ijc.70045
BibTeX
@article{deNijs2025,
author = {de Nijs, Koen and Ten Haaf, Kevin and Hubert, Juul and Moldovanu, Dana and van der Aalst, Carlijn M and Groen, Harry J M and de Jong, Pim A and Heuvelmans, Marjolein A and Oudkerk, Matthijs and de Koning, Harry J},
title = {Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.70045}
}
EUVIMED